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A B S T R A C T
Background: CHA2DS2-VASc score is the most widely preferred method for prediction of stroke risk in
patients with atrial ﬁbrillation. We hypothesized that CHA2DS2-VASc score may represent atrial
remodeling status, and therefore echocardiographic evaluation of left atrial electromechanical
remodeling can be used to identify patients with high risk.
Methods: A total of 65 patients who had documented diagnosis of paroxysmal atrial ﬁbrillation (PAF) were
divided into three risk groups according to the CHA2DS2-VASc score: patients with low risk (score = 0,
group 1), with moderate risk (score = 1, group 2), and with high risk score (score 2, group 3). We
compared groups according to atrial electromechanical intervals and left atrium mechanical functions.
Results: Atrial electromechanical intervals including inter-atrial and intra-atrial electromechanical
delay were not different between groups. However, parameters reﬂecting atrial mechanical functions
including LA phasic volumes (Vmax, Vmin and Vp) were signiﬁcantly higher in groups 2 and 3 compared
with group 1. Likewise, LA passive emptying volume (LATEV) in the groups 2 and 3 was signiﬁcantly
higher than low-risk group (14.12  8.13 ml/m2, 22.36  8.78 ml/m2, 22.89  7.23 ml/m2, p: 0.031).
Univariate analysis demonstrated that Vmax, Vmin and Vp were signiﬁcantly correlated with CHA2DS2-VASc
score (r = 0.428, r = 0.456, r = 0.451 and p < 0.001). Also, LATEV (r = 0.397, p = 0.016) and LA active emptying
volume (LAAEV) (r = 0.281, p = 0.023) were positively correlated with CHA2DS2-VASc score. In the ROC
analysis, Vmin  11 ml/m2 has the highest predictive value for CHA2DS2-VASc score 2 (88% sensitivity and
89% speciﬁcity; ROC area 0.88, p < 0.001, CI [0.76–0.99]).
Conclusion: Echocardiographic evaluation of left atrial electromechanical function might represent a
useful method to identify patients with high risk.
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Atrial ﬁbrillation (AF) is the most common cardiac rhythm
disturbance, occurring in up to 10% of the population older than
80 years [1]. AF is a major risk factor for thromboembolic events* Corresponding author at: Sakarya University Training and Research Hospital,
Adnan Menderes Street, 54000 Sakarya, Turkey. Tel.: +90 532 6064117;
fax: +90 264 2759192.
E-mail address: bulentvatan@hotmail.com (M.B. Vatan).
http://dx.doi.org/10.1016/j.jjcc.2015.02.009
0914-5087/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightswith an incidence of 7.4% per year [2]. The stroke risk is comparable
in patients with paroxysmal AF (PAF) to those with permanent AF
[3]. Risk stratiﬁcation is essential to determine thromboembolism
risk and to identify patients eligible for anticoagulation. Numerous
risk stratiﬁcation models have been proposed to predict stroke risk
in patients with non-valvular AF. Among them, CHA2DS2-VASc
score is the most widely preferred method in clinical practice. It is
based on clinical risk factors such as congestive heart failure,
hypertension, age >65–75 years, diabetes mellitus, vascular
disease, female sex, previous history of stroke or transient ischemic
attack (TIA) [4,5]. The association between the individual risk reserved.
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functional remodeling have been proposed [6]. Electrical and
structural remodeling of the left atrium maintain AF and may be
responsible for the progression of incidental and paroxysmal AF to
persistent and permanent AF [7]. Persistent AF has been proposed
as a risk factor for unsuccessful AF ablation outcomes [8]. The
process of atrial remodeling includes atrial enlargement, low atrial
contractile reserve, and prolonged atrial conduction time [9]. Also,
as a consequence of atrial electromechanical remodeling, atrial
myocardial ﬁbrosis, blood stasis and hypercoagulability ensues
which may lead to thrombus formation [10–12]. Thus, CHA2DS2-
VASc score may reﬂect deleterious effects of the clinical risk factors
on the left atrium resulting with left atrial electromechanical
remodeling.
Conventional and tissue Doppler echocardiography is a non-
invasive and simple method in the assessment of left atrial
electromechanical function [13]. The aim of the present study is to
evaluate the association between LA electromechanical function
and the CHA2DS2-VASc score, and also to deﬁne some basic
echocardiographic parameters associated with higher CHA2DS2-
VASc risk score in patients with PAF.
Methods
A total of 65 patients who had documented diagnosis of PAF
were enrolled in this study. The diagnosis was based on sustained
AF attack which persists more than 1 h and lasts spontaneously for
7 days on the 12-lead electrocardiography (ECG). Patients with
permanent AF, rheumatic valvular heart disease, history of prior AF
ablation, under the treatment of Class 1 and 3 antiarrhythmic
drugs and recurrent PAF episodes documented during 4 weeks
after the last PAF were excluded from the study. The patients were
divided into three groups according to the CHA2DS2-VASc score:
group 1 with low-risk score (score = 0), group 2 with moderate risk
(score = 1), and group 3 with high-risk score (score 2). We
compared groups by atrial electromechanical interval and left
atrium mechanical function. The study was approved by The
Ethical Committee of Sakarya University School of Medicine.
Standard echocardiographic evaluation
Echocardiographic measurements were obtained at 4 weeks
after the PAF attack. Standard echocardiographic examinations
were performed in all patients using a Philips IE33 xMatrix cardiac
ultrasound system with multifrequency transducers (Andover,
MA, USA). All measurements were recorded as average of three
cardiac cycles according to the standards of American Society of
Echocardiography. Left ventricle ejection fraction (LVEF) was
calculated by Simpson’s method [14]. Left ventricle end-diastolic
and end-systolic dimensions were measured in the parasternal
long-axis view. Left ventricle mass was assessed according to the
Devereux method [15].
Atrial electromechanical interval
Atrial electromechanical interval was evaluated by pulsed
tissue Doppler (TDI) echocardiography with a 2–4 MHz probe. On
the apical-four-chamber view, the pulsed TDI cursor was posi-
tioned parallel to the annular motion. Spectral pulsed-wave
Doppler signal ﬁlters were adjusted until a Nyquist limit of
15–20 cm/s, and using the minimal optimal gain to obtain the best
signal-to-noise ratio. The monitor sweep speed was set to 50–
100 mm/s to optimize the spectral display of myocardial velocities.
In the apical-four-chamber view, the velocities were subse-
quently recorded at the level of the left ventricle lateral mitral
annulus, septal mitral annulus, and right ventricle tricuspidannulus. Velocity pattern was presented by a positive myocardial
systolic wave (Sm) and two negative diastolic waves: early (Em)
and atrial (Am). Atrial electromechanical interval (PA) was
measured as the time from the beginning of P wave on the surface
ECG to peak of the Am wave velocity. PA interval was obtained
from the lateral mitral annulus (PA lateral), septal mitral annulus
(PA septal), and tricuspid annulus (PA tricuspid). The difference
between PA lateral and PA tricuspid (PA lateral  PA tricuspid) was
deﬁned as inter-atrial electromechanical delay, and the difference
between PA septum and PA tricuspid (PA septum  Pa tricuspid) as
intra-atrial electromechanical delay.
Left atrial mechanical function
The most useful method in the assessment of left atrium (LA)
function is based on the measurement of LA phasic volumes. LA phasic
volumes were measured by the modiﬁed biplane Simpson’s method
in four- and two-chamber apical views. Maximum volume (Vmax) was
measured at end-systole just before the opening of the mitral valve,
minimal volume (Vmin) at end-diastole just before mitral valve
closure, and the volume just before the atrial systole was measured at
the beginning of the P wave on the ECG (Vp). The following three
parameters, reﬂecting the phasic function of the LA, were calculated
from the volumes: LA passive emptying volume (LAPEV) = Vmax Vp,
LA active emptying volume (LAAEV) = Vp Vmin, LA total emptying
volume (LATEV) = Vmax Vmin, LA passive emptying fraction
(LAPEF) = (Vmax Vp)/Vmax 100, LA active emptying fraction
(LAAEF) = (Vp Vmin)/Vp 100, and LA expansion index (LAEI) =
(Vmax Vmin)/Vmin 100.
Statistical analysis
Categorical variables are shown as counts (n) and percentages
(%) and continuous data were presented as the mean  standard
deviation. Chi-square test was used to compare the categorical
variables. Kruskal–Wallis H test was used to compare the continuous
data among low-, moderate- and high-risk groups according to
CHA2DS2-VASc score (for pairwise comparisons Bonferroni adjusted
Mann–Whitney U test was used). Spearman’s correlation coefﬁcients
were used to determine the correlations between CHA2DS2-VASc
score and echocardiographic parameters.
Receiver operating characteristic (ROC) curve analysis was
performed to deﬁne thresholds for echocardiographic parameters
for predicting high CHA2DS2-VASc score with corresponding
speciﬁcity and sensitivity. Two-sided p values of <0.05 were
considered statistically signiﬁcant. Analyses were performed using
statistical software (IBM SPSS Statistics 20, SPSS Inc., An IBM Corp.,
Armonk, NY).
Results
The study population included 28 men and 37 women with the
mean age of 55  12 years. Among this population, 4 patients had
previous history of stroke, 42 had hypertension, 6 had diabetes
mellitus, 6 had coronary artery or the other vascular disease, and
3 had congestive heart failure. The baseline clinical characteristics
such as age, sex, hypertension, vascular disease, and previous history
of stroke were different in the groups (Table 1).
Atrial electromechanical interval
The mean PA lateral, PA septum, and PA tricuspid intervals were
69.61  12.93 ms, 54.58  12.56 ms, and 39.2  9.59 ms, respective-
ly. Regarding the echocardiographic parameters, PA lateral
(68.67  11.79 ms, 68.94  12.78 ms, 71.25  13.72 ms, p = 0.787),
PA septal (53.67  14.03 ms, 53.75  11.18 ms, 56.48  14.38 ms,
Table 1
Comparisons of the patient characteristics and echocardiographic parameters among CHA2DS2-VASc risk groups.
Low risk (n = 9) Moderate risk (n = 36) High risk (n = 20) p
Age 40  14 54  13 66  9a,b <0.001
Hypertension 0 23 (63.9%) 19 (95%)a,b <0.001
Heart failure 0 1 (2.8%) 2 (10%) 0.363
Diabetes mellitus 0 2 (5.6%) 4 (20%) 0.119
Stroke 0 0 4 (20%)a 0.008
Vascular disease 0 1 (2.8%) 5 (25%)a 0.013
Gender (female) 0 24 (66.7%) 13 (65%)a,b 0.001
CHA2DS2-VASc score
0 9 (100) 0 0
1 0 36 (100%) 0
2 0 0 13 (65%) –
3 0 0 3 (15%)
4 0 0 3 (15%)
5 0 0 1 (5%)
PA lateral (ms) 68.67  11.79 68.94  12.78 71.25  13.72 0.787
PA septal (ms) 53.67  14.03 53.75  11.18 56.48  14.38 0.516
PA tricuspid (ms) 40.67  11.04 38.89  7.63 39.13  12.49 0.955
Inter-atrial electromechanical delay (ms) 28.03  9.43 29.64  11.12 31.72  9.13 0.653
Intra-atrial electromechanical delay (ms) 13.05  6.16 14.86  8.77 17.41  15.75 0.912
Vmax (ml/m
2) 23.44  10.89 39.69  13.65a 42.9  12.83a 0.002
Vmin (ml/m
2) 9.42  3.53 17.61  7.25a 19.65  7.43a 0.001
Vp (ml/m
2) 14.17  6.41 26.48  9.77a 30.35  11.92a 0.001
LA passive volume (ml/m2) 9.11  5.45 13.69  7.83 12.58  4.89 0.202
LA active volume (ml/m2) 6.18  3.85 8.93  4.53 10.42  5.35 0.118
LA total volume (ml/m2) 14.12  8.13 22.36  8.78a 22.89  7.23a 0.031
LA passive emptying fraction 0.36  0.11 0.33  0.12 0.29  0.10 0.280
LA active emptying fraction 0.31  0.13 0.33  0.12 0.34  0.9 0.888
LA expansion index 1.71  0.54 1.40  0.62 1.27  0.47 0.104
LA anterior–posterior diameter (mm) 35.1  3.0 35.6  2.8 35.6  2.4 0.857
Data were shown as mean  standard deviation and n (%). Two-sided p values of <0.05 were considered statistically signiﬁcant and indicated in bold.
PA: time interval from the onset of the P wave to the peak of the Am wave; Vmax: maximal left atrial volume; Vmin: minimal left atrial volume; Vp: left atrial volume at the
beginning of atrial systole; LA: left atrium.
a There was statistically signiﬁcant difference from low-risk group.
b There was statistically signiﬁcant difference from moderate-risk group.
Table 2
Correlations between CHA2DS2-VASc scores and echocardiographic parameters.
CHA2DS2-VASc risk score
r p
PA lateral (ms) 0.110 0.385
PA septal (ms) 0.151 0.230
PA tricuspid (ms) 0.094 0.456
Inter-atrial electromechanical delay (ms) 0.228 0.068
Intra-atrial electromechanical delay (ms) 0.075 0.550
Vmax (ml/m
2) 0.428 <0.001
Vmin (ml/m
2) 0.456 <0.001
Vp (ml/m
2) 0.451 <0.001
LA passive volume (ml/m2) 0.161 0.200
LA active volume (ml/m2) 0.281 0.023
LA total volume (ml/m2) 0.297 0.016
LA passive fraction 0.206 0.100
LA active fraction 0.069 0.587
LA expansion index 0.238 0.056
r: Spearman’s correlation coefﬁcient.
PA: time interval from the onset of the P wave to the peak of the Am wave; LA:
left atrium; Vmax: maximal left atrial volume; Vmin: minimal left atrial volume;
Vp: left atrial volume at the beginning of atrial systole. Two-sided p values of
<0.05 were considered statistically signiﬁcant and indicated in bold.
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39.13  12.49 ms, p = 0.955) intervals were similar in low-, moder-
ate- and high-risk groups. Likewise, inter-atrial (28.03  9.43 ms,
29.64  11.12 ms, 31.72  9.13 ms, p = 0.653) and intra-atrial elec-
tromechanical delay (13.05  6.16 ms, 14.86  8.77 ms, 17.41 
15.75 ms, p = 0.912) were not different between groups (Table 1).
Left atrial mechanical function
The mean anterior–posterior diameters of the left atrium were
similar between groups (35.1  3.0 mm in group 1, 35.6  2.8 mm in
group 2, and 35.6  2.4 mm in group 3). There was no statistical
difference between the mean LA diameters and CHA2DS2-VASc score
levels (p = 0.857). The mean volumes of left atrium (Vmax, Vmin, Vp, and
Vtotal) were 36.42  13.01 ml/m2, 17.10  6.79 ml/m2, 25.96  9.96 ml/
m2, and 21.38  8.21 ml/m2, respectively. The LA volumes (Vmax, Vmin,
and Vp) were signiﬁcantly higher in groups 2 and 3 as compared to group
1. Likewise, LATEV in groups 2 and 3 were signiﬁcantly higher than that
of low-risk group (corresponding LATEV for groups 1, 2 and 3 were
14.12  8.13 ml/m2, 22.36  8.78 ml/m2, and 22.89  7.23 ml/m2,
respectively; p = 0.031). Nevermore, other LA mechanical function
parameters including LAPEV, LAAEV, LAPEF, LAAEF, and LAEI were
subsequently similar between each group (Table 1).
The correlation of atrial electromechanical parameters and
CHA2DS2-VASc score
Univariate regression analysis was used to determine correla-
tion between left atrial electromechanical functions and
CHA2DS2-VASc score. Univariate analysis demonstrated that Vmax,
Vmin and Vp were signiﬁcantly correlated with CHA2DS2-VASc
score (r = 0.428, r = 0.456, r = 0.451 and p < 0.001 for Vmax, Vmin and
Vp, respectively). Also, LATEV and LAAEV were positively correlatedwith higher CHA2DS2-VASc score (r = 0.397, p = 0.016 and
r = 0.281, p = 0.023 for LATEV and LAAEV, respectively). However,
there was no association between atrial electromechanical interval
parameters and CHA2DS2-VASc score levels (Table 2).
The valuable echocardiographic parameters for predicting high
CHA2DS2-VASc score
The receiver-operator characteristic (ROC) was used to test the
diagnostic value of various echocardiographic parameters of atrial
Fig. 1. Diagnostic value of receiver operating characteristics (ROC) curve of echocardiographic parameters [Vmax: maximal left atrial volume; Vmin: minimal left atrial volume;
Vp: left atrial volume at the beginning of atrial systole].
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score 2. Vmax  25 ml/m2 had a 88% sensitivity and 78%
speciﬁcity (ROC area 0.85, p < 0.001, CI [0.71–0.99]),
Vmin  11 ml/m2 had a 88% sensitivity and 89% speciﬁcity (ROC
area 0.88, p < 0.001, CI [0.76–0.99]) and Vp  18 ml/m2 had a
86% sensitivity and 89% speciﬁcity (ROC area 0.88, p < 0.001, CI
[0.76–1.0]) for predicting CHA2DS2-VASc score 2 (Fig. 1).
Discussion
In our study, we demonstrated a link between LA mechanical
remodeling and CHA2DS2-VASc score in patients with PAF. We
also revealed that echocardiographic parameters reﬂecting LA
mechanical remodeling, Vmax, Vmin and Vp, had a predictive value in
assessing CHA2DS2-VASc risk score of 2. However, no signiﬁcant
correlation was found between electrical remodeling of the left
atrium and this scoring system.
CHA2DS2-VASc score has been widely applied in clinical
practice to stratify stroke risk and to identify patients eligible
for anticoagulation in patients with PAF [4,5].
Although CHA2DS2-VASc is an excellent predictor of stroke, the
pathophysiologic mechanism is not yet fully understood. Neverthe-
less, PAF and concomitant stroke risk factors in CHA2DS2-VASc score
can lead to extensive electrophysiological and ultrastructural
abnormalities in LA, including alterations in the expression of ion
channels, changes in atrial refractoriness, structural changes in atrial
myocytes (increase in cell size, perinuclear accumulation of
glycogen, central loss of sarcomeres, fragmentation of sarcoplasmic
reticulum, and the changes in mitochondrial shape), and ﬁbroelastic
inﬁltration of the extracellular matrix. The ultrastructural changes
may be partly or wholly responsible for atrial enlargement, loss
of atrial contractility and increased atrial chamber stiffness
[9–11,14–16]. These structural remodelings of the LA in PAF
patients could contribute to further echocardiographic changes.
LA anterior–posterior diameter as measured with M-mode is
most commonly used in daily clinical practice in assessing LA
mechanical remodeling [17]. However, a weak relation between
the LA anterior–posterior diameter and stroke risk in AF had beenshown in previous studies [18]. Our results demonstrated robust
relationship among LA phasic volumes (Vmax, Vmin, and Vp), phasic
functions (LATEV and LAAEV) and the CHA2DS2-VASc score. The
anterolateral portion of the LA predominantly enlarges in the early
phases of remodeling. Therefore, predominant enlargement of LA
in the medial–lateral and superior–inferior dimensions could alter
LA geometry. Thus, anterior–posterior diameter may not represent
true size of LA [19]. LA size is more accurately reﬂected by a
measurement of volume rather than area or linear dimension.
Furthermore, evaluation of the LA phasic volumes and functions
has been shown to be highly feasible and reliable in assessing
alteration in the LA geometry and function. The American Society
of Echocardiography and the European Association of Echocardi-
ography also recommend the measurement of LA phasic volumes
and functions by ellipsoid model and Simpson’s method in four-
and two-chamber apical views [17]. For these reasons, indexed LA
volume measurements were used to assess LA mechanical
remodeling in our study.
The leading risk factors for stroke such as age, hypertension,
heart failure and diabetes mellitus are clinically measurable
indicators promoting atrial remodeling. Early identiﬁcation of
these risk factors and appropriate treatment can prevent, even
reverse LA remodeling. These risk factors presumably exert
cumulative effects in the left atrial ultrastructure [20–27]. In
our study, the patients with extensive stroke risk factors or high
CHA2DS2-VASc score had signiﬁcantly more serious LA mechani-
cal remodeling status.
Aging is one of the risk factors for stroke in PAF. Age-related
ﬁbrosis and intracellular age-related changes result in longer atrial
conduction time, LA dilation and decreased LA conduit function
[20]. Other important and well-established risk factors are
hypertension and heart failure. The underlying pathophysiological
link for hypertension or heart failure leading to LA remodeling is
atrial pressure and/or volume overload as well as diastolic
ventricular dysfunction which may lead to atrial dilatation and
ﬁbrosis. As LV ﬁlling pressures progressively increase, left atrium
enlarges, the atrial preload reservoir function increases to upper
limit, and the LA serves predominantly as a conduit. The authors
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chronic heart failure have increased left atrial size and LA contractile
dysfunction [21,22]. Kleemann et al. had previously described that
LV ejection fraction <40% is an independent predictor of left atrial
appendage thrombus and dense spontaneous echo contrast
[23]. Toh et al. showed that the combination of LA volume and
atrial contractile function measurement may be helpful in predict-
ing the risk of stroke in patients with hypertension [24]. Moreover,
diabetes mellitus is one of the most common concomitant diseases
in patients with AF [25]. The studies indicated that glucose and
insulin disturbance can directly affect the atrial myocytes [26]. Left
atrial enlargement, low atrial voltage and longer atrial conduction
time have been associated with diabetes mellitus and abnormal
glucose tolerance [27]. Illien et al. also demonstrated that diabetes
mellitus and old age were strongly associated with lower peak
emptying velocity of LAA [28]. Besides these common risk factors,
data are scarce on association of atherosclerotic vascular disease and
female sex with left atrial remodeling properties [26].
Various atrial remodeling parameters were also recently
studied in permanent AF. These studies demonstrated that the
degree of atrial electroanatomical remodeling was directly related
to the risk of stroke in patients with atrial ﬁbrillation [29,30]. A
study conducted by Chao et al. evaluated whether atrial
electromechanical interval (PA–PDI) was a signiﬁcant predictor
of stroke after successful catheter ablation of AF. They revealed
that the PA–PDI interval was a useful parameter which may
identify patients with high risk of stroke after ablation of AF [31]. In
our study, we did not intend to evaluate predictive value of left
atrial electromechanical function on future stroke development.
Chao et al. also investigated electrical remodeling of the LA in a
patient with PAF. They showed that atrial electromechanical
interval was closely associated with CHADS2 score [32]. Converse-
ly, we demonstrated that CHA2DS2-VASc score was not signiﬁ-
cantly correlated with echocardiographic parameters including
atrial conduction time, inter-atrial electromechanical delay, and
intra-atrial electromechanical delay in PAF. Extensive evidence
indicates that structural remodeling commonly caused by LA
volume and pressure overload is associated with interstitial
ﬁbrosis contributing to the reentry in AF. Atrial ﬁbrosis is also
associated with prolongation of tissue conduction times [33].
Accordingly, atrial mechanical remodeling such as changes in left
atrial volume may develop earlier than electrical remodeling.
Considering PAF as an early stage of overt atrial ﬁbrillation and
cross-sectional design of present study, we could not have
demonstrated atrial electrical remodeling in contrast to signiﬁcant
changes concerning structural remodeling. In addition, it is well
known that the electrical impulse transmitting from sinus node to
the left atrium is conducted by different pathways. However, the
measurement of atrial electromechanical delay was obtained from
only three points at the annulus level in our study. This may be the
second reason of the negative result.
In clinical practice, accurate assessment of LA function or
concomitant events requires several, rather than single quantita-
tive echocardiographic analysis [34]. So we intended to deﬁne
basic and single echocardiographic parameter to predict the
CHA2DS2-VASc score of 2. We revealed that Vmax  25 ml/m2
(ROC area 0.85), Vmin  11 ml/m2 (ROC area 0.88), and Vp  18 ml/
m2 (ROC area 0.88) were valuable parameters for predicting
CHA2DS2-VASc score 2.
The 2012 version of the European Society of Cardiology
Committee for Practice (ESC) practical guideline for AF suggested
antithrombotic therapy to be individualized based on the
CHA2DS2-VASc score [35]. Oral anticoagulants are strongly
recommended in patients with a CHA2DS2-VASc score of 2.
For patients with a CHA2DS2-VASc score of 1, a weak recommen-
dation for oral anticoagulant therapy is made. The CHA2DS2-VAScscore of 0 is deﬁned as low risk and no additional anticoagulant
recommended. We revealed that CHA2DS2-VASc score of 2 might
truly represent high LA remodeling level, who would suffer from
strokes in the future. The results of our study also implied that LA
mechanical remodeling parameters obtained from basic echocar-
diographic technique may be useful to reﬁne risk assessment and
identify eligible patients for anticoagulation.
In conclusion, CHA2DS2-VASc score represents not only a
clinical risk scheme for stroke, but is also associated with atrial
mechanical remodeling which is important for thromboembolic
events in patients with PAF. Also, atrial mechanical remodeling
parameters can offer incremental predictive value for the
identiﬁcation of patients with higher CHA2DS2-VASc score of
2. Although, left ventricle ejection fraction is the only echocardio-
graphic parameter represented in CHA2DS2-VASc score, echocar-
diographic evaluation of left atrial electromechanical function may
serve as a useful method to identify patients with high risk.
Limitations
There are some limitations of this study. First, the population of
our study was relatively small. Highly selected patients with PAF
were included in our study, since atrial electromechanical interval
can only be measured in individuals with sinus rhythm. Most
patients included in this study had relatively small LA size and
volume. Further larger, prospective investigations involving the
patients with permanent AF and larger LA size are required to
conﬁrm our results. Second, the duration from last PAF attack may
affect the atrial electromechanical function. Although, the duration
between the last PAF attack and echocardiographic study was
longer than 4 weeks in our study, the recovery of atrial stunning
after AF termination may prolong. Moreover, asymptomatic
shorter duration PAF attacks may be neglected during this period.
Third, measurements of atrial electromechanical intervals were
obtained only in three points at the annulus level. This condition
might have led to underestimation of electromechanical delay in
the present study.
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